Skip to main content
Fig. 4 | Arthritis Research & Therapy

Fig. 4

From: CTLA4-Ig treatment induces M1–M2 shift in cultured monocyte-derived macrophages from healthy subjects and rheumatoid arthritis patients

Fig. 4

Protein synthesis of M2 phenotype markers in RA-MDMs treated with CTLA4-Ig. Western blotting and related densitometric analysis of CD163, CD204, CD206, and GAPDH in cultured RA-MDMs maintained in normal growth medium without (white bar) or with CTLA4-Ig (abatacept) treatment at a concentration of 100 μg/mL (dark grey bar) and 500 μg/mL (black bar) for 24 and 48 h. The final results were obtained from seven independent in vitro experiments

Back to article page